Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Yoga and mindfulness may help cancer survivors heal from within

NCT ID NCT07161713

Symptom relief Sponsor: Barbara Nemesure Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jul 21, 2026 · Updated 4 times

Summary

This study tests whether yoga and mindfulness programs can improve quality of life, reduce inflammation, and even affect gene activity in people who have survived lung, colon, or non-Hodgkin's lymphoma cancer. One hundred survivors, at least six months past treatment, will be randomly assigned to either oncology-informed yoga or a mindfulness program called SMART. The goal is to see if these mind-body practices help with emotional and physical well-being.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
yoga and mindfulness-based stress reduction (SMART)
What this could lead to
If it works, this could point toward a simple, drug-free way to help cancer survivors feel better and potentially reduce long-term health risks.
What could go wrong
This is a small pilot study, so results may not apply to everyone. The benefits may be modest, and the study cannot prove that yoga or mindfulness directly changes disease outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults over 18 years old * Primary diagnosis: Lung Cancer, Colon Cancer and Non-Hodgkin's lymphoma (NHL) * Six months post cancer-directed treatment (chemotherapy, targeted and immunotherapy). Patients with active disease (e.g. metastatic colorectal cancer) who are not receiving any cancer-directed treatment are eligible. * Able to provide a saliva sample * Gives informed consent and agrees to be randomly assigned * Able to complete the questionnaire(s) in English. Exclusion Criteria: * Adults with primary anal and/or primary rectal cancer. * Adult cancer survivors who are currently on an active treatment regimen. * Oral or any pathological conditions that can limit the ability to produce saliva. * Unable to participate in full length study period and follow up thereafter. * Is pregnant or plan to become pregnant during the study period. * Currently practicing yoga or SMART * Those on corticosteroid therapy. * Documented fall or syncope within the last 6 months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer (colon cancer, breast cancer, lymphoma, chronic lymphoma leukemia, multiple myeloma) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast neoplasm cancer colon carcinoma colonic neoplasm disease lung adenocarcinoma lung cancer lung neoplasm lymphoma neoplasm non-Hodgkin lymphoma plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer (colon cancer, breast cancer, lymphoma, chronic lymphoma leukemia, multiple myeloma) Cancer survivors Cancer survivorship Colon cancer Lung adenocarcinoma Lung adenocarcinoma metastatic Lung adenocarcinoma stage I Lung adenocarcinoma stage II Lung adenocarcinoma stage III Lung adenocarcinoma stage IIIB/IV Lung adenocarcinoma stage IV Lung cancer (diagnosis) NHL NHL - non-Hodgkin'S lymphoma

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Stony Brook University Cancer Center

    RECRUITING

    Stony Brook, New York, 11794, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.